Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Is Abbott Wavering Over Alere?

This article was originally published in Clinica

Executive Summary

A non-committal response from Abbott Labs CEO Miles White about the progress of the company’s proposed acquisition of Alere, which is in the midst of a federal investigation over potentially corrupt sales practices abroad, has raised doubts about the $5.8bn transaction. White’s refusal to reaffirm the diagnostic giant’s commitment to the deal slightly eclipsed the positive financial figures it posted for the first quarter this year.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst